Vascular hemorrhagic diseases: coping with them with Numantec

malattie emorragiche vascolari

Vascular hemorrhagic diseases involve the vascular system, and can affect blood circulation, coagulation, and the overall health of blood vessels.
In addition to timely specific treatments, these diseases should be addressed with appropriate, safe, and effective medical devices.

Blood coagulation system and hemostasis

Blood clotting is a physiological process by which, at certain times and in certain ways, a portion of fluid blood is transformed into a clot. This is a necessary transformation for the body, which would otherwise have to deal with far more serious situations, such as excessive blood loss or creation of dangerous clots (thrombi). However, the blood clotting system can have defects that impair the normal performance of certain functions of the body.

Associated with the blood clotting system is hemostasis, a process that the body activates in order to prevent or stop bleeding. In fact, hemostasis is useful in ensuring the fluidity of blood and the integrity of blood vessels; consequently, it results in the blockage of any vascular injury. The problem arises when hemostasis itself has abnormalities, leading to either bleeding disorders or thrombotic events.

Vascular hemorrhagic diseases: what are they?

Hemorrhagic and thrombotic disorders can arise from congenital (or genetic) or acquired abnormalities, which may become evident after birth.
These conditions are frequently acquired and often linked to other illnesses such as immune and infectious vasculitis, paraproteinemia, skin disorders, or various underlying causes.

Abnormal bleeding or unexplained bruising, easily occurring, may indicate the presence of hemorrhagic diseases. Notably, the appearance of a “purple” discoloration on the skin can serve as a primary or sole indicator of disease, particularly in cases involving structural vessel malformations like hereditary hemorrhagic telangiectasia and senile purpura.

Symptoms and diagnosis

Congenital defects may be identified through family history or the onset of symptoms during early childhood. In contrast, symptoms of acquired defects typically emerge in adulthood, independent of any known family history of bleeding disorders. These symptoms may signify an underlying condition predisposing to coagulation abnormalities, even in the absence of a prior diagnosis of a bleeding disorder.

In certain instances, hemorrhagic diseases may present symptoms characteristic of both congenital and acquired defects. Such cases often arise from a combination of abnormalities affecting the vessel wall, platelet function, and coagulation factors. Accurate diagnosis and effective treatment of these complex conditions necessitate meticulous evaluation by specialized medical professionals employing a multidisciplinary approach.

Factors such as the location and type of bleeding may also suggest whether the problem is related to abnormalities in the blood vessel wall, platelet number and function, or coagulation factors.

Gathering detailed information is crucial to the diagnostic process. Key factors considered during the analysis include the patient’s personal history and historical study of any infections (other diseases, drug intake, toxic exposure, etc.), all of which will be followed by e sami of coagulation screening and diagnostic laboratory investigations.

Numantec’s support for the treatment of vascular hemorrhagic diseases

To support healthcare professionals at every stage of treatments, the Numantec Group intervenes by offering medical devices of excellence, the result of the innovation and technologies of Delta Med, Adriamed and Pentaferte companies.

In particular, Delta Med offers vascular kits that are among the most comprehensive in the world and include:

  • Sutureless
  • Prefilled syringes
  • Needleless valves

Clear dressings, towels, and chlorhex wipes for skin disinfection

Each alternative includes the ability to be assembled in order to meet periodic medication of PICCs, MIDLINEs, CVCs, MINIMIDLINEs, and IVCs of any patient.

Adriamed, on the other hand, provides a wide range of devices intended for infusion and transfusion, including:

  • Deflussers
  • Transfusions
  • Linear extensions
  • Spiral extensions
  • Extensions with 3-way tap
  • 3-way taps
  • Suction tubes
  • Faucet ramps
  • Flow regulators
  • Needless devices, such as perforators, needless access valves
  • Easyflow elastomeric pumps

Each product is available in different sizes and lengths.

PentaFerte offers a wide selection of infusion devices. PentaFerte syringes, manufactured to high quality and safety standards, meet every capacity-related need and include:

  • Three-piece syringes with needle
  • Three-piece syringes without needle
  • Residual 3-piece syringes
  • Large capacity syringes
  • Hypodermic needles

The Numantec Group proudly and determinedly brings forward innovative devices made by Delta Med, Adriamed, and Pentaferte to ensure excellence in support for those facing a bleeding disease and wishing to do so in complete safety and efficiency.